Axalta won’t sell itself or take other ‘strategic alternatives’
Citing the COVID-19 coronavirus’ disruption globally, Axalta on Tuesday announced it would end its hunt for “strategic alternatives” — a review that had examined the possibility of selling the company. “In light of the dislocation [...]